Treatment of Buerger disease (thromboangiitis obliterans) with bosentan: A case report

BMJ Case Reports

Volumn , Issue , 2009, Pages

  De Haro, Joaquin ^a   Florez, Aurora ^a   Fernandez, Jose Luis ^a   Acin, Francisco ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953313278     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.08.2008.0691     Document Type: Article

References (12)

1. Olin JW, Young JR, Graor RA, et al. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation 1990; 82(5 Suppl): IV3-8.
2. Sasajima T, Kubo Y, Inaba M, et al. Role of inf rainguinal by pass in Buerger's disease: an eighteen-year experience. Eur J Vasc Endovasc Surg 1997; 13: 186-92. (Pubitemid 27196429)
3. Agarwal VK. Long-term results of omental transplantation in chronic occlusive arterial disease (Buerger's disease) and retinal av ascular diseases (retinitis pigmentosa). Int Surg 2007; 92: 174-83.
4. Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med 2000; 343: 864-9.
5. Korn JH, Mayes M, Matucci Cerinic M, et al. Digital ulcers in systemic sclerosis: prev ention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 2004; 50: 3985-93. (Pubitemid 39643947)
6. Ramos-Casals M, Brito-Zeron P, Nardi N, et al. Successful treatment of severe Ray naud's phenomenon with bosentan in four patients with systemic sclerosis. Rheumatology (Oxford) 2004; 43: 1454-6 (Pubitemid 39480942)
7. Shionoya S. Diagnostic criteria of Buerger's disease. Int J Cardiol 1998; 66(Suppl 1): S243-5.
8. Makita S, Nakamura M, Murakami H, et al. Impaired endothelium-dependent v asorelaxation in peripheral v asculature of patients with thromboangiitis obliterans (Buerger's disease). Circulation 1996; 94(9 Suppl): II211-5. (Pubitemid 26363394)
9. Kobayashi M, Ito M, Nakagawa A, et al. Immunohistochemical analy sis of arterial wall cellular inf iltration in Buerger's disease (endarteritis obliterans). J Vasc Surg 1999; 29: 451-8 (Pubitemid 29152267)
10. Joyce JW. Buerger's disease (thromboangiitis obliterans). Rheum Dis Clin North Am 1990; 16: 463-70. (Pubitemid 20380162)
11. Lie JT. Thromboangiitis obliterans (Buerger's disease) and smokeless tobacco. Arthritis Rheum 1988; 31: 812-3.
12. Fiessinger JN, Schafer M. Trial of iloprost v ersus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study . Lancet 1990; 335: 555-7. (Pubitemid 20089238)